These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10708984)

  • 1. Anti-mutagenic structural modification by fluorine-substitution in highly mutagenic 4-methylquinoline derivatives.
    Kato T; Hakura A; Mizutani T; Saeki K
    Mutat Res; 2000 Feb; 465(1-2):173-82. PubMed ID: 10708984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of oligofluorine substitution on the mutagenicity of quinoline: a study with twelve fluoroquinoline derivatives.
    Kato T; Saeki K; Kawazoe Y; Hakura A
    Mutat Res; 1999 Feb; 439(2):149-57. PubMed ID: 10023045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent mutagenic potential of 4-methylquinoline: metabolic and mechanistic considerations.
    Saeki K; Takahashi K; Kawazoe Y
    Biol Pharm Bull; 1996 Apr; 19(4):541-6. PubMed ID: 8860954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual stimulatory and inhibitory effects of fluorine-substitution on mutagenicity: an extension of the enamine epoxide theory for activation of the quinoline nucleus.
    Saeki K; Kawai H; Kawazoe Y; Hakura A
    Biol Pharm Bull; 1997 Jun; 20(6):646-50. PubMed ID: 9212983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-carcinogenic structural modification by fluorine-substitution in aza-polycyclic aromatic hydrocarbons].
    Saeki K
    Yakugaku Zasshi; 2000 Dec; 120(12):1373-85. PubMed ID: 11193386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The inhibition by flavonoids of 2-amino-3-methylimidazo[4,5-f]quinoline metabolic activation to a mutagen: a structure-activity relationship study.
    Edenharder R; Rauscher R; Platt KL
    Mutat Res; 1997 Sep; 379(1):21-32. PubMed ID: 9330619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.
    Kumar S; Sikka HC; Dubey SK; Czech A; Geddie N; Wang CX; LaVoie EJ
    Cancer Res; 1989 Jan; 49(1):20-4. PubMed ID: 2908847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism of mutagenicity-deprived 3-fluoroquinoline: comparison with mutagenic quinoline.
    Saeki K; Takahashi K; Kawazoe Y
    Biol Pharm Bull; 1993 Mar; 16(3):232-4. PubMed ID: 8364465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimutagenic effects and possible mechanisms of action of vitamins and related compounds against genotoxic heterocyclic amines from cooked food.
    Edenharder R; Worf-Wandelburg A; Decker M; Platt KL
    Mutat Res; 1999 Jul; 444(1):235-48. PubMed ID: 10477359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenic activity of three synthetic isomers of the food carcinogen 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) in the Ames test.
    Vikse R; Klungsøyr L; Grivas S
    Mutat Res; 1993 Dec; 319(4):273-8. PubMed ID: 7504200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytochromes P450 in cynomolgus monkeys mutagenically activate 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) but not 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx).
    Sadrieh N; Snyderwine EG
    Carcinogenesis; 1995 Jul; 16(7):1549-55. PubMed ID: 7614688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tryptamine on the mutagenic activity of 2-amino-3-methylimidazo(4,5-f) quinoline (IQ) and related azaarenes in the Ames test.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1987 Jan; 2(1):51-6. PubMed ID: 3331694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsomal activation of 2-amino-3-methylimidazo[4,5-f]quinoline, a pyrolysate of sardine and beef extracts, to a mutagenic intermediate.
    Yamazoe Y; Shimada M; Kamataki T; Kato R
    Cancer Res; 1983 Dec; 43(12 Pt 1):5768-74. PubMed ID: 6416669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of fluorine substitution on benzo[j]fluoranthene genotoxicity.
    Weyand EH; He ZM; Ghodrati F; Wu Y; Marshall MV; LaVoie EJ
    Chem Biol Interact; 1992 Sep; 84(1):37-53. PubMed ID: 1394615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
    Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K
    Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenic activity of the methyl and phenyl derivatives of the food mutagen 2-amino-3-methylimidazo[4,5-f]quinoxaline (IQx) in the Ames test.
    Vikse R; Knapstad A; Klungsøyr L; Grivas S
    Mutat Res; 1993 Jan; 298(3):207-14. PubMed ID: 7678155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-activity relationships of anthraquinones as inhibitors of 7-ethoxycoumarin O-deethylase and mutagenicity of 2-amino-3-methylimidazo[4,5-f]quinoline.
    Hao NJ; Huang MP; Lee H
    Mutat Res; 1995 May; 328(2):183-91. PubMed ID: 7739602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic activation of 2-amino-3-methylimidazo(4,5-f)quinoline by hepatic preparations--contribution of the cytosolic fraction and its significance to strain differences.
    Abu-Shakra A; Ioannides C; Walker R
    Mutagenesis; 1986 Sep; 1(5):367-70. PubMed ID: 3331675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandin-H synthase mediated metabolism and mutagenic activation of 2-amino-3-methylimidazo [4,5-f] quinoline (IQ).
    Wolz E; Wild D; Degen GH
    Arch Toxicol; 1995; 69(3):171-9. PubMed ID: 7717873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genotoxic activity of the N-acetylated metabolites of the food mutagens 2-amino-3-methylimidazo[4,5-f]quinoline (IQ) and 2-amino-3,4-dimethylimidazo[4,5-f]quinoline (MeIQ).
    Brunborg G; Holme JA; Alexander J; Becher G; Hongslo JK
    Mutagenesis; 1988 Jul; 3(4):303-9. PubMed ID: 3062317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.